- Upcoming Webinar - Jun 6, 2013
- Upcoming Webinar - May 30, 2013
- Upcoming Webinar - Jun 25, 2013
- Upcoming Webinar - Jun 11, 2013
- Upcoming Webinar - Jun 13, 2013
View Sample (PDF)
Highlights on this Page
Publication Details
Subscriptions include print and electronic issues
- Frequency: biweekly (24 issues/year)
- Pages: 8
- Format: Print and PDF versions
ISSN: 1530-3438
Pub Code: NDBN-11WEB
3 Easy Ways to Order
- Secure Shopping Cart
- 1-year Subscription: Order now!
- 2-month Trial Subscription: Order now!
- Call 800-521-4323
- Print a form to fax or mail
Drug Benefit News
A hard-hitting newsletter for health plans, PBMs, pharma companies and employers. Published biweekly, it delivers timely news, proven cost management strategies and unique data gathered in AIS's own surveys of PBMs and pharmacy benefit vendors. Coverage includes news and strategies related to the use of generics and OTC drugs, formulary decisions, evidence-based medicine, changes in drug pricing, PBM transparency, changes in Part D and other federal initiatives, and much more.
News, Data and Business Strategies for Health Plans, Employers, PBMs and Pharma Companies
Drug Benefit News is a biweekly newsletter with:
- Insight into events that have a big impact on pharmacy benefit costs, such as drug purchasing arrangements, lawsuits, Medicare Part D changes and more.
- Timely coverage of pharmacy benefit-related business and government news, including the impact of consolidations, mergers and acquisitions on the industry.
- Expert analysis of new plan designs, comparative-effectiveness research and its’ impact on formulary development, and the increasing use of alternative pharmacy networks to reduce employer costs.
Drug Benefit News focuses on issues and events that have a big impact on the pharmacy benefit and drug costs, including:
- Ways that generic drug launches and the growth in specialty pharmacy may impact payers,
- New plan designs to promote formulary compliance and the use of lower-cost therapeutic alternatives, including OTC products,
- Effective strategies for improving medication compliance and adherence,
- Use of evidence-based medicine to control drug costs, and
- The effect of changes in the Medicare Part D benefit on generic drug utilization trends and medication therapy management.
As a subscriber to Drug Benefit News, you receive:
- 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered First Class by U.S. Mail and electronically (optional),
- E-News Alerts whenever important news breaks, and
- Access to a subscriber-only Web page with:
- Searchable archives of past articles,
- Exclusive data with results from AIS’s quarterly surveys of PBMs and other pharmacy benefit vendors,
- Convenient library with PDFs of back issues,
- Recent stories of interest and hot topic articles grouped for convenient reading, and
- Regular postings from your editor.
Rely on Drug Benefit News for timely news and data on the business of pharmaceuticals ... and get practical cost management strategies from experts throughout the industry. Subscribe today!
Companies participating in the pharmacy benefit management, specialty pharmacy or specialty infusion industries: Click here to participate in AIS’s Quarterly Survey of PBMs.
Written By
Drug Benefit News is written by an editorial team with extensive experience in pharma/health care business publishing. Editor Lauren Flynn Kelly, who served as editor of DBN from 2004 to 2005 and returned to AIS in 2011, has been covering health business issues for almost a decade. Managing Editor Angela Maas has an extensive background in editing, reporting and writing for both trade and consumer publications. Angela also is the managing editor of AIS’s Web and e-mail news content, and the monthly newsletter Specialty Pharmacy News. Executive Editor Jill Brown is a veteran health care reporter who brings an intelligent perspective on the forces reshaping the health care industry. And AIS’s director of databases and directories, Susan Namovicz-Peat, contributes exclusive data from AIS’s Quarterly Survey of PBMs.
Written For
- Managers of HMOs, PPOs and other managed care companies
- Purchasers, employers, pharmacy benefit companies
- Managers in the pharmaceutical industry
AIS Guarantee
When you subscribe to Drug Benefit News, your satisfaction is fully guaranteed. If you are not completely satisfied with the newsletter within the first 30 days, just cancel and receive a prompt 100% refund. After your first 30 days, you may cancel at any time in the year ahead and receive a full prompt refund for all unmailed issues.
Shipping Information
Electronic (PDF) versions of the newsletter are available, on the newsletter’s subscriber-only Web page, on the day of publication. Recipients should whitelist aisalert@aishealth.com to ensure delivery of the e-mail notification of new issues. Print newsletters are mailed 1st class through the U.S. Postal Service. You should receive your first issue within 5-7 business days of your order. A one-time $12 shipping and handling charge will be applied to your order.
View Sample (PDF)
Drug Benefit News